Advancing Pharmacological Treatments for Opioid Use Disorder (ADaPT-OUD): an Implementation Trial in Eight Veterans Health Administration Facilities
Authors:
- Hildi J. HagedornHHHildi J. Hagedorn
- Allison M. GustavsonAGAllison M. Gustavson
- Princess E. AcklandPAPrincess E. Ackland
- Ann BangerterABAnn Bangerter
- Mark BounthavongMBMark Bounthavong
- Barbara ClothierBCBarbara Clothier
- Alex H. S. HarrisAHAlex H. S. Harris
- Marie E. KennyMKMarie E. Kenny
- Siamak NoorbaloochiSNSiamak Noorbaloochi
- Hope A. SalamehHSHope A. Salameh
- Adam J. GordonAGAdam J. Gordon
- 3 January 2022
- journal article
- research article
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 37 (14) , 3594-3602
Abstract
Background Identifying effective strategies to improve access to medication treatments for opioid use disorder (MOUD) is imperative. Within the Veterans Health Administration (VHA), provision of MOUD varies significantly, requiring development and testing of implementation strategies that target facilities with low provision of MOUD. Objective Determine the effectiveness of external facilitation in increasing the provision of MOUD among VHA facilities with low baseline provision of MOUD compared to matched controls. Design Pre-post, block randomized study designed to compare facility-level outcomes in a stratified sample of eligible facilities. Four blocks (two intervention facilities in each) were defined by median splits of both the ratio of patients with OUD receiving MOUD and number of patients with OUD not currently receiving MOUD (i.e., number of actionable patients). Intervention facilities participated in a 12-month implementation intervention. Participants VHA facilities in the lowest quartile of MOUD provision (35 facilities), eight of which were randomly assigned to participate in the intervention (two per block) with twenty-seven serving as matched controls by block. Intervention External facilitation included assessment of local barriers/facilitators, formation of a local implementation team, a site visit for action planning and training/education, cross-facility quarterly calls, monthly coaching calls, and consultation. Main Measures Pre- to post-change in the facility-level ratio of patients with an OUD diagnosis receiving MOUD compared to control facilities. Key Results Intervention facilities significantly increased the ratio of patients with OUD receiving MOUD from an average of 18% at baseline to 30% 1 year later, with an absolute difference of 12% (95% confidence interval [CI]: 6.6%, 17.0%). The difference in differences between intervention and control facilities was 3.0% (95% CI: − 0.2%. 6.7%). The impact of the intervention varied by block, with smaller, less complex facilities more likely to outperform matched controls. Conclusions Intensive external facilitation improved the adoption of MOUD in most low-performing facilities and may enhance adoption beyond other interventions less tailored to individual facility contexts.Keywords
Funding Information
- veteran administrations health services research and development investigator initiated research project (16-145)
- Minneapolis Center of Innovation, Center for Care Delivery and Outcomes Research (CIN 13-406)
- veteran administrations health services research and development informatics, decision-enhancement, and analytic sciences (ideas) center of innovation ((CIN 13-414)[AJG])
- Veterans Health Administration Office of Academic Affiliations Advanced Fellowship in Clinical and Health Services Research (TPH 67-000)
This publication has 36 references indexed in Scilit:
- Receipt of opioid agonist treatment in the Veterans Health Administration: Facility and patient factorsDrug and Alcohol Dependence, 2012
- Barriers to Use of Pharmacotherapy for Addiction Disorders and How to Overcome ThemCurrent Psychiatry Reports, 2011
- Facilitators and barriers in implementing buprenorphine in the Veterans Health Administration.Psychology of Addictive Behaviors, 2011
- Societal Costs of Prescription Opioid Abuse, Dependence, and Misuse in the United StatesPain Medicine, 2011
- Adoption and Implementation of Medications in Addiction Treatment ProgramsJournal of Addiction Medicine, 2011
- Methadone maintenance therapy versus no opioid replacement therapy for opioid dependenceCochrane Database of Systematic Reviews, 2009
- Integrating hepatitis prevention services into a substance use disorder clinicJournal of Substance Abuse Treatment, 2007
- Reexamining Organizational Configurations: An Update, Validation, and Expansion of the Taxonomy of Health Networks and SystemsHealth Services Research, 2004
- A Controlled Trial Comparing Buprenorphine and Methadone Maintenance in Opioid DependenceArchives of General Psychiatry, 1996
- Buprenorphine versus Methadone Maintenance for Opioid DependenceJournal of Nervous & Mental Disease, 1993